例如:"NBL1", "4681", "drought"
收藏
144501 KRT80

144501

KRT80

keratin 80

protein-coding

Homo sapiens

基因描述

Type Description
Definition keratin 80

研究结论

Date Results Publications
2019-11-16 13:01:00 KRT80 was an independent prognostic biomarker for CRC and promoted CRC migration and invasion by interacting with PRKDC via activation of the AKT pathway. 30262880
2019-06-15 12:28:00 Study demonstrated that the type II keratin topological associating domain undergoes epigenetic reprogramming in aromatase inhibitors-resistant ER-alpha positive breast cancer cells, leading to KRT80 upregulation. KRT80 expression is driven by de novo enhancer activation by SREBP1. KRT80 levels correlate with stiffer tumors and associates with poor survival in ER-alpha positive breast cancer patients. 31073170
2011-03-05 11:09:00 Alternative splice variants, K80 and K80.1 distribute differently in epithelia of hair and skin. 20843789

名称对应

Type IDs
Synonymous KB20
Gene
UniProtKB-ID: K2C80_HUMAN
UniprotKB: Q6KB66
UniParc: UPI0000160118, UPI00001A9D69, UPI00002335E2
EMBL: BC065180, BX537567, AJ717743, CH471111
Ensembl: ENSG00000167767
KO: hsa:144501
Nucleutide sequences
EMBL-CDS: EAW58237.1, CAD97784.1, AAH65180.1, CAG30732.1
Ensembl_TRS: ENST00000313234, ENST00000394815
Protein sequencees
Ensembl_PRO: ENSP00000369361, ENSP00000378292
RefSeq: NP_001074961.1, XP_005268733.1, NP_872313.2
Others
UniRef100: UniRef100_Q6KB66
UniRef90: UniRef90_Q6KB66
UniRef50: UniRef50_Q6KB66
UniGene: Hs.140978
CCDS: CCDS41784.1, CCDS8821.2

全选

{{proteinIndex+1}}
mRNA Protein UniprotKB Description
Refseq {{protein.nucleotideVersion}}

Ensembl: {{protein.nucleotideEnsembl}}

{{protein.proteinVersion}}

Ensembl: {{protein.proteinEnsembl}}

{{uniprot}}
Definition: {{{protein.definition}}}

Transcript Veriant:{{protein.transcriptVeriant}}

Status: {{protein.status}}

Location ( {{protein.positionStart}}..{{protein.positionEnd}} )

暂无数据

研究热度

热点单位
排名 科研单位 文献
{{affIndex+1}}

{{aff.value}}

{{aff.size}}

目前还没有研究热点单位

热点人员
排名 研究人员 文献
{{authorIndex+1}}

{{author.value}}

{{author.size}}

目前还没有研究热点人员